Full Text
CO2 Outcomes-Based Agreements and Real-World Data for Health Technology Reassessment of Orphan Drugs: Learnings from Belgium

Abstract

Authors

A Blonda K Facey Van de Vijver I Y Denier I Huys S Simoens

Back to Volume 27, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×